Detailseite
Projekt Druckansicht

Plasma Zell Interaktionen in der Dermatologie

Fachliche Zuordnung Medizinische Physik, Biomedizinische Technik
Förderung Förderung von 2012 bis 2017
Projektkennung Deutsche Forschungsgemeinschaft (DFG) - Projektnummer 225433025
 
Erstellungsjahr 2018

Zusammenfassung der Projektergebnisse

One of the main topics of the PlaCID project ("Plasma Cell Interactions in Dermatology", PAK816) was to provide the researchers of the package group with stable, well characterized, and optimized plasma sources. Hence, we investigated two different atmospheric-pressure plasma sources to evaluate their efficacy for biomedical applications, namely a dielectric barrier discharge (DBD) operated without gas flow but strong fields to the surface and a microscaled atmospheric pressure plasma jet (µAPPJ) with gas flow and lacking external fields. The sources were characterized regarding electrical and plasma parameters, such as power density and its correlation to electron density. We investigated their reactive species chemistry to optimize the output for plasma-medical applications. For a DBD operated in air, investigation of oxygen and ozone distributions in front of surfaces have been conducted and compared to a plasma chemical model. Ambient air inherently yields an uncertainty regarding the gas composition and, thus, in the produced reactive species. This disadvantage is not present for the second device, a µAPPJ operated in helium with a small admixture of oxygen. However, during the characterization of the µAPPJ, it was found out that reproducibility was not sufficient enough to allow reasonable plasma-medical investigations. Minimizing impurities in the plasma was found to be of major importance. First investigations of our partners at the HHU showed irregular production of nitric oxide (NO). Therefore, the development of a reproducible reference source was promoted and pushed forward due to the results gained in the PlaCID project. This reference source has been finalized and published within a European COST action (MP1101 ’Biomedical Applications of Atmospheric Pressure Plasmas’). The new reference jet also allows operation at a low flow of 0.25 slm, preventing dry-out of the skin which was identified as a major problem for biomedical experiments within the PlaCID project. The device is now shared within the groups of the Plasma2Cell cooperation at the RUB (PAK728 and PAK816) and the medical partners at HHU. The impact of plasma was analyzed by applying different biological assays in cooperation with the other project partner Havenith-Neven (RUB) and Suschek/Opländer (HHU). We have learned that the plasma sources readily modify various biological samples within the applied parameter range. Especially thiols seem to be a primary target for oxidative as well as nitrosative modifications.

Projektbezogene Publikationen (Auswahl)

 
 

Zusatzinformationen

Textvergrößerung und Kontrastanpassung